CLINICAL_TRIALS
trial_result
· 2018-02-05
Clinical Trial Update: Effects of Dapagliflozin 10 mg on Insulin Resistance in Patients With Type 2 Diabetes Mellitus [Phase 4]
Summary
Phase 4 trial assessing the effects of dapagliflozin 10 mg on insulin resistance in patients with type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2018-02-05